General Information of Drug Transporter (DT)
DT ID DTD0180 Transporter Info
Gene Name SLC25A20
Transporter Name Carnitine/acylcarnitine translocase
Gene ID
788
UniProt ID
O43772
Post-Translational Modification of This DT
Overview of SLC25A20 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Methylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Alanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [1]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A20 Alanine 2 has the potential to affect its expression or activity.

  Lysine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Inhibiting the activity of SLC25A20 [2]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

148

Experimental Material(s)

Rat liver mitochondria

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A20 lysine 148 have been reported to inhibit its activity.

  PTM Phenomenon 2

Inhibiting the activity of SLC25A20 [2]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

157

Experimental Material(s)

Rat liver mitochondria

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A20 lysine 157 have been reported to inhibit its activity.

  PTM Phenomenon 3

Inhibiting the activity of SLC25A20 [2]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

170

Experimental Material(s)

Rat liver mitochondria

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A20 lysine 170 have been reported to inhibit its activity.

  PTM Phenomenon 4

Inhibiting the activity of SLC25A20 [2]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

244

Experimental Material(s)

Rat liver mitochondria

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A20 lysine 244 have been reported to inhibit its activity.

Methylation

  Arginine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [3]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

166

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A20 Arginine 166 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

136

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A20 Cystine 136 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A20 [5]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

155

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A20 Cystine 155 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A20 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

143

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 143 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A20 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

144

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 144 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A20 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

147

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 147 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A20 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

183

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 183 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A20 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

205

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 205 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A20 [10] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

208

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Serine 208 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

189

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Threonine 189 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A20 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

198

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Threonine 198 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

186

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Tyrosine 186 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A20 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

190

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A20 Tyrosine 190 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A20 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

244

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A20 Lysine 244 has the potential to affect its expression or activity.
References
1 N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24.
2 Post-translational modification by acetylation regulates the mitochondrial carnitine/acylcarnitine transport protein. Mol Cell Biochem. 2017 Feb;426(1-2):65-73.
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: MCAT_HUMAN)
4 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
6 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
7 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
8 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
9 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
10 Insulin increases phosphorylation of mitochondrial proteins in human skeletal muscle in vivo. J Proteome Res. 2014 May 2;13(5):2359-69.
11 Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol Cell Proteomics. 2011 Jan;10(1):M110.000299.
12 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
13 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
14 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.